Literature DB >> 7833277

Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma.

S Kocialkowski1, F Pezzella, H Morrison, M Jones, S Laha, A L Harris, D Y Mason, K C Gatter.   

Abstract

We have investigated the relationship between the p53 genotype and phenotype in a series of 22 high-grade non-Hodgkin's lymphomas (NHLs) in which we sequenced the p53 gene open reading frame (exons 2-11). Immunostaining for p53 was already available for these cases. Mutations were found in 10/22 cases (45%) and 3/10 were in exons 4 or 10 outside the classic 'hot spot' regions (exons 5-8). Comparison with immunostaining indicated that, besides cases with the 'expected' patterns (in which gene mutation and protein detection were either both present or both absent) there were also cases in which p53 protein was detected in the absence of any mutation and those with a mutant gene in which the protein was undetectable. These data show that: (1) in high-grade NHLs mutations frequently occur outside the classic hot spot regions and (2) staining for p53 is not predictive of the status of the gene, i.e. whether or not a mutation is present. Therefore in order to document p53 involvement in lymphoid tumours it is necessary both to sequence at least the whole translated open reading frame of the gene and to show evidence of protein expression by immunostaining.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7833277     DOI: 10.1111/j.1365-2141.1995.tb08911.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Screening of the entire coding region of p53 in low grade lymphoproliferative disorders.

Authors:  T J Bromidge; D J Howe
Journal:  Mol Pathol       Date:  2000-08

2.  p53 protein expression in non-Hodgkin's lymphoma. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1.

Authors:  M Tzardi; C Kouvidou; I Panayiotides; K Stefanaki; D Rontogianni; E Zois; K Koutsoubi; G Eliopoulos; G Delides; P Kanavaros
Journal:  Clin Mol Pathol       Date:  1996-10

3.  Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features.

Authors:  Eduardo M Queiroga; Gabriela Gualco; Lawrence M Weiss; Dirk P Dittmer; Iguaracyra Araujo; Claudette E N Klumb; William J Harrington; Carlos E Bacchi
Journal:  Am J Clin Pathol       Date:  2008-12       Impact factor: 2.493

4.  Effects of prostaglandin E2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion.

Authors:  Shabirul Haque; Xiao Jie Yan; Lisa Rosen; Steven McCormick; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  FASEB J       Date:  2013-10-21       Impact factor: 5.191

5.  p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer?

Authors:  D N Poller; K J Baxter; N A Shepherd
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  p53 mutation and expression in lymphoma.

Authors:  D J Adamson; W D Thompson; A A Dawson; B Bennett; N E Haites
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.